PPP2CB
Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform
Also known as: PP2AB_HUMAN, PP2Abeta
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P62714
- Gene
- PPP2CB
- Ensembl
- ENSG00000104695
- Chromosome
- 8
- Canonical length
- 309 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes the phosphatase 2A catalytic subunit. Protein phosphatase 2A is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. This gene encodes a beta isoform of the catalytic subunit. [provided by RefSeq, Mar 2010]
Canonical amino-acid sequenceUniProt
309 residues, UniProt reviewed canonical sequence.
>P62714|PPP2CB
1 MDDKAFTKEL DQWVEQLNEC KQLNENQVRT LCEKAKEILT KESNVQEVRC PVTVCGDVHG
61 QFHDLMELFR IGGKSPDTNY LFMGDYVDRG YYSVETVTLL VALKVRYPER ITILRGNHES
121 RQITQVYGFY DECLRKYGNA NVWKYFTDLF DYLPLTALVD GQIFCLHGGL SPSIDTLDHI
181 RALDRLQEVP HEGPMCDLLW SDPDDRGGWG ISPRGAGYTF GQDISETFNH ANGLTLVSRA
241 HQLVMEGYNW CHDRNVVTIF SAPNYCYRCG NQAAIMELDD TLKYSFLQFD PAPRRGEPHV
301 TRRTPDYFLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PPP2CB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 214 nTPM
Expression across tissuesHPA
Tissue
- amygdala: 214 nTPM
- midbrain: 196 nTPM
- hippocampal formation: 195 nTPM
- ovary: 190 nTPM
- spinal cord: 187 nTPM
- cerebral cortex: 186 nTPM
Single-cell type
- peritubular myoid cells: 422 nCPM
- alveolar cells type 1: 353 nCPM
- esophageal apical cells: 307 nCPM
- endometrial stromal cells: 304 nCPM
- ovarian stromal cells: 267 nCPM
- alveolar cells type 2: 251 nCPM
Immune cell
- NK-cell: 3.8 nTPM
- plasmacytoid DC: 3.8 nTPM
- basophil: 3.4 nTPM
- intermediate monocyte: 3.1 nTPM
- memory B-cell: 2.9 nTPM
- classical monocyte: 2.5 nTPM
Brain region
- thalamus: 208 nTPM
- medulla oblongata: 192 nTPM
- white matter: 190 nTPM
- spinal cord: 187 nTPM
- basal ganglia: 183 nTPM
- hypothalamus: 177 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0.34
- gnomAD missense Z
- 3.11
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic mitochondrial changes
- mitotic cell cycle
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of gene expression
- negative regulation of Ras protein signal transduction
- negative regulation of tumor necrosis factor-mediated signaling pathway
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein dephosphorylation
- regulation of microtubule polymerization
- regulation of neurofibrillary tangle assembly
- response to antibiotic
- response to endoplasmic reticulum stress
- response to hydrogen peroxide
- response to lead ion
Molecular functions
- metal ion binding
- protein serine/threonine phosphatase activity
- tau protein binding
- transmembrane transporter binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PPP2CB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PPP2CB as an antibody target. Whether an autoantibody or antibody against PPP2CB could matter depends on whether native PPP2CB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PPP2CB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PPP2CB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...